Published in Stroke on October 22, 2009
Heterogeneity in the penumbra. J Cereb Blood Flow Metab (2011) 1.33
Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update. World J Radiol (2012) 0.87
Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations. J Exp Stroke Transl Med (2009) 0.78
Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis. Neurol Med Chir (Tokyo) (2015) 0.75
Role of Genetic Variation in Collateral Circulation in the Evolution of Acute Stroke: A Multimodal Magnetic Resonance Imaging Study. Stroke (2017) 0.75
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Stroke. Lancet (2008) 9.51
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol (2008) 9.02
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet (2015) 7.16
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Pooling of animal experimental data reveals influence of study design and publication bias. Stroke (2004) 4.37
Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust (2003) 4.24
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke (2010) 3.43
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab (2005) 3.20
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol (2002) 2.79
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med (2012) 2.39
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke (2008) 2.39
Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke (2008) 2.32
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 2.25
Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol (2002) 2.25
The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000. J Acquir Immune Defic Syndr (2003) 2.18
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit. Med J Aust (2002) 2.13
Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location. J Neurol Sci (2013) 2.11
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
National healthline responses to a stroke scenario: implications for early intervention. Stroke (2007) 2.06
Emergency department workload increase: dependence on primary care? J Emerg Med (2009) 2.04
Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke (2011) 2.03
Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin? Stroke (2004) 2.02
Effective prophylaxis for deep venous thrombosis after stroke: both low-dose anticoagulation and stockings for most cases. Stroke (2004) 2.00
Low Alberta Stroke Program Early CT score (ASPECTS) associated with malignant middle cerebral artery infarction. Cerebrovasc Dis (2014) 1.99
Does abnormal circadian blood pressure pattern really matter in patients with transient ischemic attack or minor stroke? Stroke (2014) 1.98
Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med (2010) 1.97
World Stroke Organization global stroke services guidelines and action plan. Int J Stroke (2014) 1.94
Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis (2010) 1.93
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Biotic stress globally downregulates photosynthesis genes. Plant Cell Environ (2010) 1.82
Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke (2004) 1.81
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging (2009) 1.76
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Climate change: resetting plant-insect interactions. Plant Physiol (2012) 1.75
Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Med J Aust (2007) 1.71
Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology (2013) 1.69
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab (2010) 1.68
Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet J (2004) 1.67
Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women. Neuroepidemiology (2008) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
The physiological significance of the time-to-maximum (Tmax) parameter in perfusion MRI. Stroke (2010) 1.62
Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust (2003) 1.61
Molecular interactions between the specialist herbivore Manduca sexta (Lepidoptera, Sphingidae) and its natural host Nicotiana attenuata. VII. Changes in the plant's proteome. Plant Physiol (2006) 1.59
Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke (2003) 1.59
Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2004) 1.59
Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol (2009) 1.59
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke (2011) 1.52
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis (2013) 1.52
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke (2009) 1.49
Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke. J Clin Neurosci (2010) 1.49
Association between early returns and frequent ED visits at a rural academic medical center. Am J Emerg Med (2003) 1.48
Source of microembolic signals in patients with high-grade carotid stenosis. Stroke (2002) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 1.47
Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008). Med J Aust (2010) 1.47
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation (2005) 1.46
Patients with transient ischemic attack or minor stroke should be admitted to hospital: for. Stroke (2006) 1.45
Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol (2011) 1.44